Cargando…

Development of children’s hymenoptera venom allergy quality of life scale (CHVAQoLS)

BACKGROUND: Venom allergy is a rare but life-threatening disease and may have a considerable impact on the health-related quality of life (HRQoL) of patients, especially children. This paper presents development of the HRQoL scale for children and adolescents with Hymenoptera venom allergy (HVA). ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cichocka-Jarosz, Ewa, Brzyski, Piotr, Tobiasz-Adamczyk, Beata, Lis, Grzegorz, Pietrzyk, Jacek J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750314/ https://www.ncbi.nlm.nih.gov/pubmed/23915879 http://dx.doi.org/10.1186/2045-7022-3-25

Ejemplares similares

Development of Parents’ of Children with Hymenoptera Venom Allergy Quality of Life Scale (PoCHVAQoLS)
por: Brzyski, Piotr, et al.
Publicado: (2015)

Congruence of the current practices in Hymenoptera venom allergic patients in Poland with EAACI guidelines
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2011)

Health-related quality of life in Polish adolescents with Hymenoptera venom allergy treated with venom immunotherapy
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2012)

Stinging insect identification in children with Hymenoptera venom allergy and their parents
por: Kaszuba, Jagoda, et al.
Publicado: (2023)

Current practices in diagnosis of Hymenoptera venom allergy in Poland
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2021)

Venom allergy treatment practices in Poland in comparison to guidelines: next edition of the national audit
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2019)

Skin prick tests are not useful for the qualification for venom immunotherapy in children
por: Cichocka-Jarosz, Ewa, et al.
Publicado: (2023)

Is the clinical manifestation of anaphylaxis in children influenced by the trigger of reaction?
por: Tarczoñ, Izabela, et al.
Publicado: (2020)

Intervention in anaphylaxis: the experience of one paediatric centre based on NORA reports
por: Tarczoń, Izabela, et al.
Publicado: (2020)

Risk factors in Hymenoptera venom allergy
por: Ruëff, F., et al.
Publicado: (2017)

Component resolved diagnostics for hymenoptera venom allergy
por: Jakob, Thilo, et al.
Publicado: (2017)

Proteomic features characterization of Hymenoptera venom allergy
por: Matuszewska, Eliza, et al.
Publicado: (2019)

Hymenoptera venom allergy: work disability and occupational impact of venom immunotherapy
por: Paolocci, Giulia, et al.
Publicado: (2014)

Types of laryngomalacia in children: interrelationship between clinical course and comorbid conditions
por: Kusak, Beata, et al.
Publicado: (2016)

Benefits and limitations of sting challenge in hymenoptera venom allergy
por: Aßmus, Katharina, et al.
Publicado: (2021)

Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom Allergy
por: Blank, Simon, et al.
Publicado: (2020)

9α,11β-PGF(2), a Prostaglandin D(2) Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients
por: Nittner-Marszalska, Marita, et al.
Publicado: (2015)

Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy
por: Niedoszytko, Marek, et al.
Publicado: (2013)

Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens
por: Perez-Riverol, Amilcar, et al.
Publicado: (2015)

Diagnosis of Hymenoptera Venom Allergy: State of the Art, Challenges, and Perspectives
por: Matysiak, Joanna, et al.
Publicado: (2022)

90 Improving the Diagnosis of Hymenoptera Venom Allergy: Component Resolved Diagnosis
por: Cifuentes, Liliana, et al.
Publicado: (2012)

New Biomarkers of Hymenoptera Venom Allergy in a Group of Inflammation Factors
por: Packi, Kacper, et al.
Publicado: (2021)

Platelet‐activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy?
por: Bilò, Maria Beatrice, et al.
Publicado: (2021)

Diagnostics in Hymenoptera venom allergy: current concepts and developments with special focus on molecular allergy diagnostics
por: Jakob, Thilo, et al.
Publicado: (2017)

Add-on treatment with nebulized hypertonic saline in a child with plastic bronchitis after the Glenn procedure,
por: Lis, Grzegorz, et al.
Publicado: (2014)

PD41 - Risk factors for side effects during venom immunotherapy in children with hymenoptera venom allergy
por: Yavuz, Suleyman Tolga, et al.
Publicado: (2014)

Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
por: Sahiner, Umit Murat, et al.
Publicado: (2019)

Allergen-specific immunotherapy of Hymenoptera venom allergy – also a matter of diagnosis
por: Schiener, Maximilian, et al.
Publicado: (2017)

Molecular diagnostics and inhibition of cross‐reactive carbohydrate determinants in Hymenoptera venom allergy
por: Jovanovic, Dragana, et al.
Publicado: (2023)

Hymenoptera Allergens: From Venom to “Venome”
por: Spillner, Edzard, et al.
Publicado: (2014)

Allergy and sensitization to Hymenoptera venoms in unreferred adults with a high risk of sting exposure
por: Zink, Alexander, et al.
Publicado: (2019)

Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes
por: Blank, Simon, et al.
Publicado: (2020)

Impact of specific immunotherapy and sting challenge on the quality of life in patients with hymenoptera venom allergy
por: Eitel, Tamara, et al.
Publicado: (2021)

Analysis of Hymenoptera venom allergy in own material. Clinical evaluation of reactions following stings, in patients qualified for venom immunotherapy
por: Chciałowski, Andrzej, et al.
Publicado: (2018)

The Honeybee Venom Major Allergen Api m 10 (Icarapin) and Its Role in Diagnostics and Treatment of Hymenoptera Venom Allergy
por: Jakob, Thilo, et al.
Publicado: (2020)

Allergen immunotherapy for insect venom allergy: protocol for a systematic review
por: Dhami, Sangeeta, et al.
Publicado: (2016)

First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy
por: Sills, Eric Scott, et al.
Publicado: (2004)

Clinical Features and the Diagnostic Value of Component Allergen-Specific IgE in Hymenoptera Venom Allergy
por: Shin, Yoo Seob, et al.
Publicado: (2012)

Hymenoptera venom allergy in outdoor workers: Occupational exposure, clinical features and effects of allergen immunotherapy
por: Toletone, Alessandra, et al.
Publicado: (2016)

Single‐cell profiling reveals novel cellular heterogeneity of monocytes during Hymenoptera venom allergy
por: Chao, Wen‐Cheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a9oodirb2a9jv63ka9bsl43snu